Clinical trial
Prospective Multicentre Randomized Double-Blind Placebo-Controlled Parallel Group Study on the Efficacy and Tolerability of StroVac� in Patients With Recurrent Symptomatic Bacterial Urinary Tract Infections
To demonstrate the clinical efficacy and tolerability of the inactivated germs of specified enterobacteria contained in StroVac� in recurrent acute uncomplicated symptomatic bacterial urinary tract infections as compared to placebo.
Category | Value |
---|---|
Study start date | 2011-11-21 |